Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Correlation between clinical course and CEA levels during chemotherapy.

G Luporini, F Mangiarotti, P Fraschini

    Bollettino Dell'Istituto Sieroterapico Milanese
    |January 1, 1976
    PubMed
    Summary

    Carcinoembryonic antigen (CEA) levels correlate with clinical progress in gastroenteric tumors, especially during chemotherapy. Monitoring CEA aids in assessing treatment effectiveness and guiding therapeutic decisions for gastric and colorectal cancers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    ItaLynch: an ongoing Italian study to evaluate the feasibility of mainstreaming the diagnosis of Lynch syndrome in colorectal cancer patients.

    ESMO gastrointestinal oncology·2026
    Same author

    Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2020
    Same author

    Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic.

    Orphanet journal of rare diseases·2020
    Same author

    Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    Annals of oncology : official journal of the European Society for Medical Oncology·2020
    Same author

    The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.

    European journal of cancer (Oxford, England : 1990)·2019
    Same author

    Consensus and controversies regarding follow-up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology.

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2018

    Area of Science:

    • Oncology
    • Clinical Chemistry

    Background:

    • Assessing the correlation between Carcinoembryonic Antigen (CEA) levels and clinical outcomes in gastroenteric tumors is crucial, particularly during chemotherapy.
    • This study evaluated CEA assay results in 330 patients with gastric and colorectal neoplasms to understand its prognostic and monitoring value.

    Observation:

    • CEA test positivity varied by tumor type, stage, and differentiation, being higher in colorectal compared to gastric neoplasms and in adenocarcinomas versus undifferentiated forms.
    • Left-sided colon tumors showed higher CEA positivity (66.6%) than right-sided forms (38%).
    • Post-radical surgery, 72% of patients normalized CEA levels.

    Findings:

    • In patients undergoing radical surgery without chemotherapy, CEA levels closely correlated with clinical evolution in 98% of cases.

    Related Experiment Videos

  • For advanced neoplasms treated with chemotherapy, an 88% correlation was observed between CEA response and clinical response (p < 0.001).
  • Normalized CEA levels post-surgery indicate successful treatment.
  • Implications:

    • The CEA test is a valuable tool for monitoring the effectiveness of surgical and chemotherapeutic treatments in gastroenteric cancers.
    • CEA monitoring can inform decisions on adjusting or selecting more effective chemotherapeutic strategies.
    • Serial CEA assays can guide patient management and predict treatment outcomes.